Participants receiving only bimagrumab saw an average weight loss of 10.8%, with all weight loss attributable to fat mass and lean mass increasing by 2.5%
In a yearlong Phase 3 trial, the highest dose of Lilys pill, orforglipron, lowered a measure of blood sugar called A1C by 1.9 percentage points, while the highest dose of Novos drug, marketed as Rybelsus, lowered A1C by 1.5 percentage points, when analyzing all patients regardless of discontinuations
As we always say on our Vitamin World blog, you dont need a full workout plan, a huge revamp or to seek out the extremes
Anyone considering use outside a clinical trial should talk to a qualified clinician
Davies M, Pieber TR, Hartoft-Nielsen M-L, Hansen OK, Jabbour S, Rosenstock J